In the year ended March 31, 2021, Tatva Chintan posted a profit of ₹52.26 crore on revenues of ₹300.35 crore. At the upper price band of Rs.1,083, Tatva Chintan is available at a P/E of 46x (diluted) which appears to be reasonably priced," Geojit said. Well placed to capitalize on opportunities in agrochemical sector led by proposed capacity expansions, increase in demand, R&D capabilities, and adoption of China plus one strategy by global companies. Moreover, RoE remains healthy at 32% in FY21. "Tatva Chintan has a healthy balance sheet position with lower D/E ratio of 0.54x as of FY21. The IPO investors can check their Harsha Engineers IPO allotment status online on the Linkintime website or they can check it via their bank account and Demat login as offline mode. The initial public offering (IPO) of Campus Activewear IPO witnessed a massive subscription on the last day of the public offer on April 28 as the issue was booked 51.75 times led by institutional investors. Harsha Engineers IPO listing is on September 26. Owing to shutdowns in China and lack of capacity additions in other developed countries, India stands to benefit in the export market, say analysts. Campus Activewear IPO Share Allotment: Here is how you can check status on BSE, Link Intime. Tatva Chintan also exports products to over 25 countries. It is also one of the leading global producers of an entire range of Phase Transfer Catalysts in India," says Geojit, adding that the company enjoys strong customer relationship with marquee players like Merck, Bayer AG, Asian Paints Ltd. "Tatva Chintan is the largest and only commercial manufacturer of SDAs for zeolites (used as a catalyst in several important chemical reactions) in India and enjoys the second largest position globally. Many brokerages had recommended subscribe to Tatva Chintan IPO on promising sector outlook, saying that the company is well poised to capitalize on opportunities in agrochemical sector led by proposed capacity expansions, increase in demand, R&D capabilities, and adoption of China plus one strategy by global companies. Proceeds from the fresh issue part of the IPO would be used towards expansion of the company's manufacturing facility, up-gradation of a research and development facilities and general corporate purposes. Ahead of IPO, Tatva Chintan had mopped up ₹150 crore from anchor investors. The ₹500 crore IPO comprised a fresh issue of up to ₹225 crore and an offer for sale of up to ₹275 crore. The Vadodara-based specialty chemical manufacturing company had offered shares in the price range of ₹1,073-1,083 per share.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |